ORPH (ORPH:NASDAQ) rocketted at $21, a gain of 302.3%. The stock appeared on our News Catalysts scanner on Thu, Jun 10, 2021 at 04:50 PM in the 'HALT' category. From Wed, May 26, 2021, the stock recorded 55.56% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About ORPH (ORPH:NASDAQ)
Orphazyme A/S is a Danish biotech company. It is engaged in the development of paradigm-changing medicines for the treatment of protein misfolding diseases.
Top 10 Gainers:
- ORPH (ORPH:NASDAQ), 302.3%
- Trxade Group, Inc. (MEDS:NASDAQ), 63.48%
- Sphere 3D Corp. (ANY:NASDAQ), 60.5%
- GLTO (GLTO:NASDAQ), 60%
- Axcella Health Inc. (AXLA:NASDAQ), 48.7%
- Heat Biologics, Inc. (HTBX:NASDAQ), 40.15%
- Medley Management Inc. (MDLY:NYSE), 36.64%
- Yiren Digital Ltd. (YRD:NYSE), 29.44%
- DBGI (DBGI:NASDAQ), 27.3%
- AMST (AMST:NASDAQ), 25.34%